drugset / Trial / NCT00324038
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective is to compare buprenorphine transdermal delivery system (BTDS) with standard- treatment in subjects with osteoarthritis (OA).
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 500 mg | Oral |
| Subject | Buprenorphine | Other / unclassified | 5 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 10 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 20 mg | Other |
| Comparator | Codeine | Small molecule | 8 mg | Oral |
| Comparator | Codeine | Small molecule | 15 mg | Oral |
| Comparator | Codeine | Small molecule | 30 mg | Oral |